TDP-43: new aspects of autoregulation mechanisms in RNA binding proteins and their connection with human disease

被引:43
作者
Buratti, Emanuele [1 ]
Baralle, Francisco E. [1 ]
机构
[1] ICGEB, Trieste, Italy
关键词
alternative splicing; autoregulation; hnRNP; mRNA stability; NMD; SR proteins; TDP-43; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MESSENGER-RNA; GENE-EXPRESSION; SR PROTEINS; MULTIPLE ROLES; HNRNP PROTEINS; SPLICING REGULATION; TARDBP MUTATIONS; SF2/ASF;
D O I
10.1111/j.1742-4658.2011.08257.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The maintenance of correct protein homeostasis ('proteostasis') is an essential activity of mammalian cells to preserve their vital properties and functions. Because of its importance, correct proteostasis is achieved by the cell in several ways and at several levels of each gene expression pathway. In many cases, mRNA-autoregulatory pathways based on a variety of feedback mechanisms have been observed to play a major role in keeping their concentration under control. This is especially true for RNA binding proteins because of their potential ability to bind their own pre-mRNA molecules, and in particular for two subsets of nuclear factors that are commonly referred to as heterogeneous ribonucleoproteins and serine-arginine-rich proteins. Regarding the mechanism, nonsense-mediated RNA degradation triggered by alternative splicing of their own messenger RNA is a very common autoregulation pathway to maintain constant expression levels within the cellular environment. Recently, however, alternative mechanisms other than nonsense-mediated decay have also been described to play a role for other RNA binding protein factors: serine-arginine-rich splicing factor 1 (SRSF1) and transactive response DNA binding protein 43 kDa (TDP-43). The aim of this minireview will be to discuss these old and new autoregulatory processes and their implication in disease development.
引用
收藏
页码:3530 / 3538
页数:9
相关论文
共 64 条
[1]   Aberrant RNA processing events in neurological disorders [J].
Anthony, Karen ;
Gallo, Jean-Marc .
BRAIN RESEARCH, 2010, 1338 :67-77
[2]   TDP-43 regulates its mRNA levels through a negative feedback loop [J].
Ayala, Youhna M. ;
De Conti, Laura ;
Avendano-Vazquez, S. Erendira ;
Dhir, Ashish ;
Romano, Maurizio ;
D'Ambrogio, Andrea ;
Tollervey, James ;
Ule, Jernej ;
Baralle, Marco ;
Buratti, Emanuele ;
Baralle, Francisco E. .
EMBO JOURNAL, 2011, 30 (02) :277-288
[3]   Adapting proteostasis for disease intervention [J].
Balch, William E. ;
Morimoto, Richard I. ;
Dillin, Andrew ;
Kelly, Jeffery W. .
SCIENCE, 2008, 319 (5865) :916-919
[4]   TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration [J].
Baloh, Robert H. .
FEBS JOURNAL, 2011, 278 (19) :3539-3549
[5]   TDP-43: Overview of the series [J].
Baralle, Francisco E. ;
Buratti, Emanuele .
FEBS JOURNAL, 2011, 278 (19) :3529-3529
[6]  
Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251
[7]   Nucleocytoplasmic mRNP export is an integral part of mRNP biogenesis [J].
Bjork, Petra ;
Wieslander, Lars .
CHROMOSOMA, 2011, 120 (01) :23-38
[8]  
BUDINI M, 2011, CURR ALZHEIMER RES
[9]   Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping [J].
Buratti, E ;
Dörk, T ;
Zuccato, E ;
Pagani, F ;
Romano, M ;
Baralle, FE .
EMBO JOURNAL, 2001, 20 (07) :1774-1784
[10]   Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease [J].
Buratti, Emanuele ;
Baralle, Francisco E. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 :867-878